Paloma Partners Management CO Tyme Technologies, Inc. Transaction History

Paloma Partners Management CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$0.97 - $1.77 $188,859 - $344,619	-194,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.96 - $1.89 $186,912 - $367,983	194,700 New	194,700 $238,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.